Table 5 Analysis of OS in breast cancer with specific distant organ metastasis and primary sites.
Primary site | Bone metastasis | Brain metastasis | Liver metastasis | Lung metastasis | ||||
|---|---|---|---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
UOQ | REF | REF | REF | REF | ||||
LIQ | 0.909 (0.733–1.127) | 0.383 | 0.470 (0.166–1.333) | 0.156 | 0.757 (0.471–1.218) | 0.251 | 1.132 (0.782–1.640) | 0.511 |
UIQ | 0.936 (0.791–1.106) | 0.437 | 2.086 (1.080–4.030) | 0.029 | 0.912 (0.640–1.298) | 0.608 | 1.016 (0.761–1.357) | 0.915 |
LOQ | 0.918 (0.765–1.102) | 0.358 | 0.365 (0.110–1.213) | 0.100 | 1.073 (0.780–1.477) | 0.664 | 0.778 (0.562–1.077) | 0.130 |
Axillary tail | 0.928 (0.536–1.608) | 0.790 | –b | – | – | – | 0.853 (0.234–3.107) | 0.810 |
Overlapping | 0.983 (0.872–1.107) | 0.773 | 1.716 (0.939–3.138) | 0.079 | 1.231 (0.979–1.546) | 0.075 | 1.138 (0.927–1.395) | 0.216 |
TCNPa | 1.137 (0.952–1.356) | 0.156 | 0.726 (0.255–2.064) | 0.547 | 1.170 (0.788–1.737) | 0.436 | 1.069 (0.757–1.509) | 0.704 |
